Treating elderly cancer patients: What you need to know about their physiology and specific medical needs Journal Article

  


Author: Lichtman, S. M.
Article Title: Treating elderly cancer patients: What you need to know about their physiology and specific medical needs
Abstract: By 2030, more than 20% of people in the United States will be aged 65 years or older. Approximately half of all cancers occur in this population. Because life expectancy has increased tremendously over the past century and further increases are projected, the study of cancer and aging has emerged as a critical topic in oncologic care. This article outlines key issues in caring for the older adult with cancer and offers practitioners a better understanding of the differences in physiology of these patients and their specific medical needs. © 2006 Elsevier Inc. All rights reserved.
Keywords: treatment outcome; treatment response; fludarabine; hydroxyurea; prednisone; cisplatin; doxorubicin; paclitaxel; cancer patient; cytarabine; methotrexate; rituximab; antineoplastic agent; colorectal cancer; carboplatin; dacarbazine; antineoplastic metal complex; breast cancer; etoposide; lung non small cell cancer; combination chemotherapy; creatinine; cyclophosphamide; melphalan; vincristine; practice guideline; carmustine; ifosfamide; vinblastine; patient care; nonhodgkin lymphoma; drug distribution; drug mechanism; nonsteroid antiinflammatory agent; comorbidity; drug clearance; bleomycin; tamoxifen; hematopoiesis; aging; daily life activity; drug metabolism; drug absorption; life expectancy; functional status; teniposide; creatinine clearance; cytochrome p450 3a4; kidney dysfunction
Journal Title: Community Oncology
Volume: 3
Issue: 11
ISSN: 1548-5315
Publisher: Elsevier Inc.  
Date Published: 2006-11-01
Start Page: 730
End Page: 734
Language: English
PROVIDER: scopus
DOI/URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-33845499489&partnerID=40&md5=42ea076d8947d10a05dea67096ccc0b7
Notes: --- - "Export Date: 4 June 2012" - "Source: Scopus"